PPARG and bone sarcoma: The related TLS-DDIT3 fusion protein has been shown to repress Ppar-γ2 promoter activity in U2OS human bone sarcoma-derived cells [73] but not affect Ppar-γ gene expression in mouse bone marrow-derived mesenchymal progenitor cells [65].